<DOC>
	<DOCNO>NCT02018081</DOCNO>
	<brief_summary>The aim study 1. describe levofloxacin pharmacokinetics ICU patient suffer pneumonia take account physio-pathological parameter . 2. verify clinical bacteriological efficiency know peak/Minimum Inhibitory Concentration ( MIC ) ratio &gt; 5 Area Under Curve ( AUC ) /Minimum Inhibitory Concentration ( MIC ) ratio &gt; 125 . No therapeutic drug monitoring perform study .</brief_summary>
	<brief_title>Pharmacokinetics Levofloxacin Intensive Care Unit</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>severe communityacquired pneumonia due strain sensible levofloxacin Age &gt; 18 year Informed consent SAPS II ( simplify acute physiological score ) &gt; 20 Awaited duration survival high 7 day Historic allergy levofloxacin Resistant strain levofloxacin Pregnancy Contraindications levofloxacin use , renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>pharmacokinetic study : open , prospective , monocentric</keyword>
</DOC>